Company intelligence / Profile preview

Lee’s Pharmaceutical International

Shatin, Hong Kong

Ownership: Private
Development stage: Other

Overview

Lee's Pharmaceutical has over 25 approved and marketed proprietary, generic, and licensed-in products mainly in China and its territories. It leverages internal R&D and licensed international therapies, including innovative and generic drugs across major areas such as cardiovascular, oncology, women's health, rare diseases, and more. Recent approvals include high-profile generics, anti-infectives, oncology drugs, and rare disease therapies[1][2][4][7][11].

Therapeutic areas: NephrologyCardiovascularOphthalmologyWomen's HealthInfectious DiseasesNeurologyRare DiseasesOtherHematologyDermatologyOncology
Modalities: Small moleculeBiological productPeptidesSynthetic peptide
Industry: Biotech

Partnerships

U.S., European, and Japanese pharma/biotech companies (exact names not specified)Multiple in-licensing and co-development relationships (approx. 30 international companies)

Beyond the preview

Go deeper on Lee’s Pharmaceutical International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lee’s Pharmaceutical International.

Explore the full profile